조현병 환자를 위한 정신사회적 중재

키워드

참고문헌 (60)

1. Mathers CD, "Projections of global mortality and burden of disease from 2002 to 2030", PLoS Med, 3, pp.e442~ (2006)
2. Galletly C, "Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders", Aust N Z J Psychiatry, 50, pp.410~472 (2016)
3. Hjorthøj C, "Years of potential life lost and life expectancy in schizophrenia : a systematic review and meta-analysis", Lancet Psychiatry, 4, pp.295~301 (2017)
4. Marder SR, "Physical health monitoring of patients with schizophrenia", Am J Psychiatry, 161, pp.1334~1349 (2004)
5. Marder SR, "Integrating pharmacological and psychosocial treatments for schizophrenia", Acta Psychiatr Scand Suppl, 407, pp.87~90 (2000)
6. Jukić V, "Importance of the newer generations of antipsychotics in reducing schizophrenia hospitalization rates", Psychiatr Danub, 25, pp.329~333 (2013)
7. Norman R, "Canadian treatment guidelines on psychosocial treatment of schizophrenia in adults", Can J Psychiatry, 62, pp.617~623 (2017)
8. Addington D, "Canadian practice guidelines for comprehensive community treatment for schizophrenia and schizophrenia spectrum disorders", Can J Psychiatry, 62, pp.662~672 (2017)
9. Baandrup L, "Treatment of adult patients with schizophrenia and complex mental health needs-a national clinical guideline", Nord J Psychiatry, 70, pp.231~240 (2016)
10. National Collaborating Centre for Mental Health, "Psychosis and schizophrenia in adults: the NICE guideline on treatment and management", National Institute for Health and Care Excellence, ~ (2014)
11. Scottish Intercollegiate Guidelines Network, "Management of schizophrenia (SIGN Guideline No. 131)", SIGN, ~ (2013)
12. Dixon LB, "The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements", Schizophr Bull, 36, pp.48~70 (2010)
13. Marom S, "Expressed emotion : relevance to rehospitalization in schizophrenia over 7 years", Schizophr Bull, 31, pp.751~758 (2005)
14. Grácio J, "Key elements of a family intervention for schizophrenia : a qualitative analysis of an RCT", Fam Process, 57, pp.100~112 (2018)
15. Addington J, "Canadian treatment guidelines for individuals at clinical high risk of psychosis", Can J Psychiatry, 62, pp.656~661 (2017)
16. Brabban A, "Predictors of outcome in brief cognitive behavior therapy for schizophrenia", Schizophr Bull, 35, pp.859~864 (2009)
17. 김성완, "Effects of Group Cognitive-Behavioral Therapy in Young Patients in the Early Stage of Psychosis", PSYCHIATRY INVESTIGATION, 14(5), pp.609~617 (2017), 대한신경정신의학회[DOI]
18. Mizrahi R, "Social stress and psychosis risk : common neurochemical substrates?", Neuropsychopharmacology, 41, pp.666~674 (2016)
19. Beauchamp MC, "Do personality traits matter when choosing a group therapy for early psychosis?", Psychol Psychother, 86, pp.19~32 (2013)
20. Nelson B, "Cognitive Behavioural Case Management (CBCM) for the NEURAPRO-E study. version 1" (2008), Orygen Youth Health
21. Kim KR, "Clinical efficacy of individual cognitive therapy in reducing psychiatric symptoms in people at ultra-high risk for psychosis", Early Interv Psychiatry, 5, pp.174~178 (2011)
22. Chung YC, "Group cognitivebehavioral therapy for early psychosis", Cognit Ther Res, 37, pp.403~411 (2013)
23. 이가영, "젊은 조현병 환자의 사회복귀를 위한 인지행동치료 기반 집중사례관리 증례", 대한조현병학회지, 19(1), pp.32~37 (2016), 대한조현병학회
24. Kinoshita Y, "Supported employment for adults with severe mental illness", Cochrane Database Syst Rev, 9, pp.CD008297~ (2013)
25. Mueser KT, "The NAVIGATE program for first-episode psychosis: rationale, overview, and description of psychosocial components", Psychiatr Serv, 66, pp.680~690 (2015)
26. McFarlane WR, "Employment outcomes in family-aided assertive community treatment", Am J Orthopsychiatry, 70, pp.203~214 (2000)
27. Bond GR, "Does competitive employment improve nonvocational outcomes for people with severe mental illness?", J Consult Clin Psychol, 69, pp.489~501 (2001)
28. Álvarez-Jiménez M, "Road to full recovery: longitudinal relationship between symptomatic remission and psychosocial recovery in first-episode psychosis over 7.5 years", Psychol Med, 42, pp.595~606 (2012)
29. Kim EJ, "Low dietary intake of n-3 fatty acids, niacin, folate, and vitamin C in Korean patients with schizophrenia and the development of dietary guidelines for schizophrenia", Nutr Res, 45, pp.10~18 (2017)
30. Roffman JL, "Biochemical, physiological and clinical effects of l-methylfolate in schizophrenia: a randomized controlled trial", Mol Psychiatry, 23, pp.316~322 (2018)
31. Amminger GP, "Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study", Nat Commun, 6, pp.7934~ (2015)
32. Kim SW, "Relationship between erythrocyte fatty acid composition and psychopathology in the Vienna omega-3 Ssudy", PLoS One, 11, pp.e0151417~ (2016)
33. Rimes RR, "Effects of exercise on physical and mental health, and cognitive and brain functions in schizophrenia: clinical and experimental evidence", CNS Neurol Disord Drug Targets, 14, pp.1244~1254 (2015)
34. McGorry PD, "The recognition and optimal management of early psychosis : an evidence-based reform", World Psychiatry, 1, pp.76~83 (2002)
35. Perkins DO, "Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia : a critical review and meta-analysis", Am J Psychiatry, 162, pp.1785~1804 (2005)
36. Kane JM, "Comprehensive versus usual community care for first-episode psychosis : 2-year outcomes from the NIMH RAISE early treatment program", Am J Psychiatry, 173, pp.362~372 (2016)
37. Caton CL, "The need for close monitoring of early psychosis and cooccurring substance misuse", Psychiatrist, 35, pp.241~243 (2011)
38. Barnes TR, "Comorbid substance use and age at onset of schizophrenia", Br J Psychiatry, 188, pp.237~242 (2006)
39. Crockford D, "Canadian schizophrenia guidelines : schizophrenia and other psychotic disorders with coexisting substance use disorders", Can J Psychiatry, 62, pp.624~634 (2017)
40. Na E, "Treatment of tobacco use disorders in people with mental illness", J Korean Soc Res Nicotine Tob, 6, pp.78~85 (2015)
41. Marshall M, "Assertive community treatment for people with severe mental disorders", Cochrane Database Syst Rev, 4, pp.CD001089~ (2011)
42. Brewer WJ, "Intensive case management for high-risk patients with first-episode psychosis : service model and outcomes", Lancet Psychiatry, 2, pp.29~37 (2015)
43. Morin L, "Rehabilitation interventions to promote recovery from schizophrenia : a systematic review", Front Psychiatry, 8, pp.100~ (2017)
44. van Oosterhout B, "Metacognitive training for schizophrenia spectrum patients : a meta-analysis on outcome studies", Psychol Med, 46, pp.47~57 (2016)
45. Varga E, "Efficacy of metacognitive training compared with a psychosocial rehabilitation program on social cognitive processing in schizophrenia", Eur Neuropsychopharmacol, 27, pp.S959~ (2017)
46. Nestor P, "The employment of consumers in mental health services : politically correct tokenism or genuinely useful?", Australas Psychiatry, 16, pp.344~347 (2008)
47. Pitt V, "Consumer-providers of care for adult clients of statutory mental health services", Cochrane Database Syst Rev, 3, pp.CD004807~ (2013)
48. Kendall T, "NICE v. SIGN on psychosis and schizophrenia: same roots, similar guidelines, different interpretations", Br J Psychiatry, 208, pp.316~319 (2016)
49. Craig TK, "AVATAR therapy for auditory verbal hallucinations in people with psychosis: a single-blind, randomised controlled trial", Lancet Psychiatry, 5, pp.31~40 (2018)
50. Khoury B, "Mindfulness interventions for psychosis : a meta-analysis", Schizophr Res, 150, pp.176~184 (2013)
51. Louise S, "Mindfulness-and acceptance-based interventions for psychosis : our current understanding and a meta-analysis", Schizophr Res, 192, pp.57~63 (2018)
52. Edwards J, "The recognition and management of early psychosis. A preventive approach" (1999), Cambridge University Press
53. Rickwood DJ, "Headspace-Australia’s innovation in youth mental health : who are the clients and why are they presenting?", Med J Aust, 200, pp.108~111 (2014)
54. Iyer S, "Early intervention for psychosis : a Canadian perspective", J Nerv Ment Dis, 203, pp.356~364 (2015)
55. Birchwood M, "Reducing duration of untreated psychosis : care pathways to early intervention in psychosis services", Br J Psychiatry, 203, pp.58~64 (2013)
56. National Institute for Clinical Excellence, "Implementing the early intervention in psychosis access and waiting time standard: Guidance" (2016), NHS England Publications
57. Zhang Z, "Cost-effectiveness analysis of psychosocial intervention for early stage schizophrenia in China: a randomized, one-year study", BMC Psychiatry, 14, pp.212~ (2014)
58. Correll CU, "Comparison of early intervention services vs treatment as usual for early-phase psychosis: a systematic review, meta-analysis, and metaregression", JAMA Psychiatry, 75, pp.555~565 (2018)
59. Kim SW, "Development and feasibility of smartphone application for cognitive behavioural case management of individuals with early psychosis", Early Interv Psychiatry (2017)
60. Sung-Wan Kim, "Validation of the Korean version of the 16-Item Prodromal Questionnaire in a Non-Help-Seeking College Population", PSYCHIATRY INVESTIGATION, 15(2), pp.111~117 (2018), 대한신경정신의학회[DOI]

관련 논문AI추천